Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 225 articles:
HTML format



Single Articles


    November 2021
  1. MARR I, Swe K, Henderson A, Lacey JA, et al
    Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427455. doi: 10.1093.
    PubMed     Abstract available


  2. RAUWOLF KK, Hoertnagl C, Lass-Floerl C, Groll AH, et al
    Interaction in vitro of pulmonary surfactant with antifungal agents used for treatment and prevention of invasive aspergillosis.
    J Antimicrob Chemother. 2021 Nov 11. pii: 6425642. doi: 10.1093.
    PubMed     Abstract available


  3. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  4. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  5. ENGBERG J, Vejrum LK, Madsen TV, Nielsen XC, et al
    Verification of analytical bacterial spectrum of QIAstat-Dx(R) GI V2 and Novodiag(R) Bacterial GE+ V2-0 diagnostic panels.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  6. CHEN LF, Wang TC, Chen FL, Hsu SC, et al
    Efficacy of doxycycline versus azithromycin for the treatment of rectal chlamydia: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2021 Sep 16. pii: 6371309. doi: 10.1093.
    PubMed     Abstract available


  7. DIEZ-AGUILAR M, Ekkelenkamp M, Morosini MI, Huertas N, et al
    Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
    J Antimicrob Chemother. 2021;76:2578-2585.
    PubMed     Abstract available


  8. SASS G, Larwood DJ, Martinez M, Shrestha P, et al
    Efficacy of nikkomycin Z in murine CNS coccidioidomycosis: modelling sustained-release dosing.
    J Antimicrob Chemother. 2021;76:2629-2635.
    PubMed     Abstract available


  9. GEBREMARIAM T, Gu Y, Singh S, Kitt TM, et al
    Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
    J Antimicrob Chemother. 2021;76:2636-2639.
    PubMed     Abstract available


  10. DARAGON B, Fournier D, Plesiat P, Jeannot K, et al
    Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2021;76:2586-2592.
    PubMed     Abstract available


  11. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    PubMed     Abstract available


  12. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    PubMed    


  13. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    PubMed     Abstract available


  14. RAISANEN K, Sarvikivi E, Arifulla D, Pietikainen R, et al
    Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016-20.
    J Antimicrob Chemother. 2021;76:2697-2701.
    PubMed     Abstract available


  15. BIEDRZYCKA M, Urbanowicz P, Guzek A, Brisse S, et al
    Dissemination of Klebsiella pneumoniae ST147 NDM-1 in Poland, 2015-19.
    J Antimicrob Chemother. 2021;76:2538-2545.
    PubMed     Abstract available


  16. SLAVIN MA, Chen YC, Cordonnier C, Cornely OA, et al
    When to change treatment of acute invasive aspergillosis: an expert viewpoint.
    J Antimicrob Chemother. 2021 Sep 11. pii: 6368907. doi: 10.1093.
    PubMed     Abstract available


  17. FLATEAU C, Riazi A, Cassard B, Camus M, et al
    Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
    J Antimicrob Chemother. 2021 Sep 6. pii: 6364850. doi: 10.1093.
    PubMed     Abstract available


  18. ABBOTT IJ, Mouton JW, Peleg AY, Meletiadis J, et al
    Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpoints.
    J Antimicrob Chemother. 2021 Sep 2. pii: 6362682. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  19. MARRO FC, Abad L, Blocker AJ, Laurent F, et al
    In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature.
    J Antimicrob Chemother. 2021 Aug 30. pii: 6359549. doi: 10.1093.
    PubMed     Abstract available


  20. TEDIM AP, Lanza VF, Rodriguez CM, Freitas AR, et al
    Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358700. doi: 10.1093.
    PubMed     Abstract available


  21. COUPRI D, Verneuil N, Hartke A, Liebaut A, et al
    Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358701. doi: 10.1093.
    PubMed     Abstract available


  22. CHAUVELOT P, Dupieux-Chabert C, Abad L, Souche A, et al
    Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection.
    J Antimicrob Chemother. 2021 Aug 23. pii: 6356267. doi: 10.1093.
    PubMed     Abstract available


  23. ZHU Y, Yang Q, Schwarz S, Yang W, et al
    Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA.
    J Antimicrob Chemother. 2021 Aug 18. pii: 6354200. doi: 10.1093.
    PubMed    


  24. URBANOWICZ P, Izdebski R, Baraniak A, Zabicka D, et al
    Molecular and genomic epidemiology of VIM/IMP-like metallo-beta-lactamase-producing Pseudomonas aeruginosa genotypes in Poland.
    J Antimicrob Chemother. 2021;76:2273-2284.
    PubMed     Abstract available


  25. TYDEMAN F, Craine N, Kavanagh K, Adams H, et al
    Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    J Antimicrob Chemother. 2021;76:2437-2445.
    PubMed     Abstract available


  26. MUNTEAN MM, Muntean AA, Guerin F, Cattoir V, et al
    Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.
    J Antimicrob Chemother. 2021;76:2294-2301.
    PubMed     Abstract available


  27. SIX A, Mosbahi K, Barge M, Kleanthous C, et al
    Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.
    J Antimicrob Chemother. 2021;76:2317-2324.
    PubMed     Abstract available


  28. LI R, Peng K, Xiao X, Wang Y, et al
    Characterization of novel ISAba1-bounded tet(X15)-bearing composite transposon Tn6866 in Acinetobacter variabilis.
    J Antimicrob Chemother. 2021;76:2481-2483.
    PubMed    


  29. VADLAMUDI NK, Saatchi A, Patrick DM, Rose C, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada.
    J Antimicrob Chemother. 2021;76:2419-2427.
    PubMed     Abstract available


  30. MACVANE SH, Bhalodi AA, Dare RK, Rosenbaum ER, et al
    Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest BC Kit.
    J Antimicrob Chemother. 2021;76:2453-2463.
    PubMed     Abstract available


  31. COCCITTO SN, Fioriti S, Cinthi M, Morroni G, et al
    Detection of phenicol-oxazolidinone resistance gene optrA in Aerococcus viridans from bovine faeces, Italy.
    J Antimicrob Chemother. 2021;76:2479-2481.
    PubMed    


  32. KUMAR M, Mathur T, Barman TK, Chaira T, et al
    Novel FtsZ inhibitor with potent activity against Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 11. pii: 6350072. doi: 10.1093.
    PubMed     Abstract available


  33. GITMAN MR, Alburquerque B, Chung M, van de Guchte A, et al
    Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients.
    J Antimicrob Chemother. 2021 Aug 9. pii: 6345863. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  34. VERSPORTEN A, Bruyndonckx R, Adriaenssens N, Hens N, et al
    Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  35. BRUYNDONCKX R, Adriaenssens N, Versporten A, Hens N, et al
    Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  36. ADRIAENSSENS N, Bruyndonckx R, Versporten A, Hens N, et al
    Consumption of quinolones in the community, European Union/European Economic Area, 1997-2017.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  37. LIU P, Hao Z, Liu M, Niu M, et al
    Genetic mutations in adaptive evolution of growth-independent vancomycin-tolerant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327451. doi: 10.1093.
    PubMed     Abstract available


  38. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    PubMed     Abstract available


  39. STOSIC MS, Leangapichart T, Lunha K, Jiwakanon J, et al
    Novel mcr-3.40 variant co-located with mcr-2.3 and blaCTX-M-63 on an IncHI1B/IncFIB plasmid found in Klebsiella pneumoniae from a healthy carrier in Thailand.
    J Antimicrob Chemother. 2021;76:2218-2220.
    PubMed    


  40. BABICH T, Naucler P, Valik JK, Giske CG, et al
    Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
    J Antimicrob Chemother. 2021;76:2172-2181.
    PubMed     Abstract available


  41. SCHECHNER V, Fallach N, Braun T, Temkin E, et al
    Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
    J Antimicrob Chemother. 2021;76:2182-2185.
    PubMed     Abstract available


  42. TROTT DJ, Turnidge J, Kovac JH, Simjee S, et al
    Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organisation's critically important antimicrobial list?
    J Antimicrob Chemother. 2021;76:1955-1961.
    PubMed     Abstract available


  43. PANTEL A, Nachar O, Boudet A, Loubet P, et al
    In vitro activity of dalbavancin against Gram-positive bacteria isolated from diabetic foot osteomyelitis.
    J Antimicrob Chemother. 2021;76:2057-2060.
    PubMed     Abstract available


  44. MCMURTRY TA, Barekat A, Rodriguez F, Purewal P, et al
    Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure.
    J Antimicrob Chemother. 2021 Jul 10. pii: 6318623. doi: 10.1093.
    PubMed     Abstract available


  45. ASEMPA TE, DeRosa NA, Cassino C, Lehoux D, et al
    Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
    J Antimicrob Chemother. 2021 Jul 5. pii: 6314896. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  46. KRUGER H, Ji X, Wang Y, Fessler AT, et al
    Identification of Tn553, a novel Tn554-related transposon that carries a complete blaZ-blaR1-blaI beta-lactamase operon in Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 24. pii: 6308652. doi: 10.1093.
    PubMed    


  47. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed     Abstract available


  48. PINHOLT M, Mollerup S, Boye K, Worning P, et al
    Investigation of the introduction and dissemination of vanB Enterococcus faecium in the Capital Region of Denmark and development of a rapid and accurate clone-specific vanB E. faecium PCR.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6306968. doi: 10.1093.
    PubMed     Abstract available


  49. HANAO M, Aoki K, Ishii Y, Shimuta K, et al
    Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from a ceftriaxone-susceptible lineage.
    J Antimicrob Chemother. 2021;76:1769-1775.
    PubMed     Abstract available


  50. NOBREGA DE ALMEIDA J, Francisco EC, Holguin Ruiz A, Cuellar LE, et al
    Epidemiology, clinical aspects, outcomes and prognostic factors associated with Trichosporon fungaemia: results of an international multicentre study carried out at 23 medical centres.
    J Antimicrob Chemother. 2021;76:1907-1915.
    PubMed     Abstract available


  51. ZHANEL GG, Adam HJ, Baxter M, Lagace-Wiens PRS, et al
    In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
    J Antimicrob Chemother. 2021;76:1808-1814.
    PubMed     Abstract available


  52. SIERRA Y, Gonzalez-Diaz A, Carrera-Salinas A, Berbel D, et al
    Genome-wide analysis of urogenital and respiratory multidrug-resistant Haemophilus parainfluenzae.
    J Antimicrob Chemother. 2021;76:1741-1751.
    PubMed     Abstract available


  53. SLIMINGS C, Riley TV
    Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
    J Antimicrob Chemother. 2021;76:1676-1688.
    PubMed     Abstract available


  54. DE KORNE-ELENBAAS J, Bruisten SM, de Vries HJC, Van Dam AP, et al
    Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    J Antimicrob Chemother. 2021;76:1759-1768.
    PubMed     Abstract available


  55. LE TURNIER P, El Helali N, Guilhaumou R, Pilmis B, et al
    CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective study.
    J Antimicrob Chemother. 2021 Jun 13. pii: 6297842. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  56. BERBEL D, Camara J, Gonzalez-Diaz A, Cubero M, et al
    Deciphering mobile genetic elements disseminating macrolide resistance in Streptococcus pyogenes over a 21 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2021 May 20. pii: 6279207. doi: 10.1093.
    PubMed     Abstract available


  57. SABAT AJ, Bathoorn E, Becker K, Akkerboom V, et al
    Staphylococcal cassette chromosome mec containing a novel mec gene complex, B4.
    J Antimicrob Chemother. 2021 May 15. pii: 6276546. doi: 10.1093.
    PubMed     Abstract available


  58. SUGAWARA Y, Hagiya H, Akeda Y, Takeuchi D, et al
    Community spread and acquisition of clinically relevant Escherichia coli harbouring blaNDM among healthy Japanese residents of Yangon, Myanmar.
    J Antimicrob Chemother. 2021;76:1448-1454.
    PubMed     Abstract available


  59. GALARION LH, Mohamad M, Alzeyadi Z, Randall CP, et al
    A platform for detecting cross-resistance in antibacterial drug discovery.
    J Antimicrob Chemother. 2021;76:1467-1471.
    PubMed     Abstract available


  60. FRISCH S, Boese A, Huck B, Horstmann JC, et al
    A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms.
    J Antimicrob Chemother. 2021;76:1472-1479.
    PubMed     Abstract available


  61. NAIR S, Chattaway M, Langridge GC, Gentle A, et al
    ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi.
    J Antimicrob Chemother. 2021;76:1459-1466.
    PubMed     Abstract available


  62. VAN KLEEF E, Wielders CCH, Schouls LM, Feenstra SG, et al
    National point prevalence study on carriage of multidrug-resistant microorganisms in Dutch long-term care facilities in 2018.
    J Antimicrob Chemother. 2021;76:1604-1613.
    PubMed     Abstract available


  63. BRANDIS G, Gockel J, Garoff L, Guy L, et al
    Expression of the qepA1 gene is induced under antibiotic exposure.
    J Antimicrob Chemother. 2021;76:1433-1440.
    PubMed     Abstract available


  64. KARCZEWSKI J, Brown CM, Maezato Y, Krasucki SP, et al
    Efficacy of a novel lantibiotic, CMB001, against MRSA.
    J Antimicrob Chemother. 2021;76:1532-1538.
    PubMed     Abstract available


  65. PARSELS KA, Mastro KA, Steele JM, Thomas SJ, et al
    Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections.
    J Antimicrob Chemother. 2021;76:1379-1391.
    PubMed     Abstract available


  66. BRIGGS S, Broom M, Duffy E, Everts R, et al
    Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
    J Antimicrob Chemother. 2021 May 11. pii: 6274254. doi: 10.1093.
    PubMed     Abstract available


  67. NOEL AR, Attwood M, Bowker KE, MacGowan AP, et al
    The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
    J Antimicrob Chemother. 2021 May 11. pii: 6274253. doi: 10.1093.
    PubMed     Abstract available


  68. ADAMECZ Z, Nielsen KL, Kirkby NS, Frimodt-Moller N, et al
    Aminoglycoside resistance genes in Enterococcus faecium: mismatch with phenotype.
    J Antimicrob Chemother. 2021 May 9. pii: 6272857. doi: 10.1093.
    PubMed    


  69. WANG W, Sun B
    VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
    J Antimicrob Chemother. 2021 May 5. pii: 6264898. doi: 10.1093.
    PubMed     Abstract available


  70. HAO M, Schuyler J, Zhang H, Shashkina E, et al
    Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    J Antimicrob Chemother. 2021 May 3. pii: 6263424. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  71. DEJOIES L, Sassi M, Schutz S, Moreaux J, et al
    Genetic features of the poxtA linezolid resistance gene in human enterococci from France.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6251856. doi: 10.1093.
    PubMed     Abstract available


  72. PUTSATHIT P, Hong S, George N, Hemphill C, et al
    Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6250920. doi: 10.1093.
    PubMed     Abstract available


  73. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed     Abstract available


  74. NI W, Yang D, Guan J, Xi W, et al
    In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226986. doi: 10.1093.
    PubMed     Abstract available


  75. WALKER SV, Wolke M, Plum G, Weber RE, et al
    Failure of Vitek2 to reliably detect vanB-mediated vancomycin resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225960. doi: 10.1093.
    PubMed     Abstract available


  76. LU CH, Shiau CW, Chang YC, Kung HN, et al
    SC5005 dissipates the membrane potential to kill Staphylococcus aureus persisters without detectable resistance.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225957. doi: 10.1093.
    PubMed     Abstract available


  77. MASON CY, Kanitkar T, Richardson CJ, Lanzman M, et al
    Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
    J Antimicrob Chemother. 2021;76:1323-1331.
    PubMed     Abstract available


  78. BRILHANTE M, Gobeli Brawand S, Endimiani A, Rohrbach H, et al
    Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital.
    J Antimicrob Chemother. 2021;76:1140-1149.
    PubMed     Abstract available


  79. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed     Abstract available


  80. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed     Abstract available


  81. MARIN JEO, Villatoro E, Luna MJ, Barrientos AM, et al
    Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19.
    J Antimicrob Chemother. 2021;76:1155-1159.
    PubMed     Abstract available


  82. LEE IR, Thein TL, Ang LW, Ding Y, et al
    Cefazolin versus ceftriaxone as definitive treatment for Klebsiella pneumoniae bacteraemia: a retrospective multicentre study in Singapore.
    J Antimicrob Chemother. 2021;76:1303-1310.
    PubMed     Abstract available


  83. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed     Abstract available


  84. PAI MP, Wilcox MH, Chitra S, McGovern PC, et al
    Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.
    J Antimicrob Chemother. 2021;76:1315-1322.
    PubMed     Abstract available


  85. MARIMUTHU K, Mo Y, Ling ML, Hernandez-Koutoucheva A, et al
    Household transmission of carbapenemase-producing Enterobacteriaceae: a prospective cohort study.
    J Antimicrob Chemother. 2021;76:1299-1302.
    PubMed     Abstract available


  86. CASTANEDA X, Garcia-De-la-Maria C, Gasch O, Pericas JM, et al
    Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocardit
    J Antimicrob Chemother. 2021 Apr 9. pii: 6219388. doi: 10.1093.
    PubMed     Abstract available


  87. MOSER S, Rehm S, Guertler N, Hinic V, et al
    Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6227026. doi: 10.1093.
    PubMed     Abstract available


  88. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6215053. doi: 10.1093.
    PubMed     Abstract available


  89. JIANG N, Wyres KL, Li J, Fessler AT, et al
    Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China.
    J Antimicrob Chemother. 2021 Apr 5. pii: 6210593. doi: 10.1093.
    PubMed     Abstract available


  90. CHEN YH, Lin SY, Lin YT, Tseng SP, et al
    Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
    J Antimicrob Chemother. 2021 Apr 2. pii: 6208785. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  91. BRUSAMARELLO C, Daley AJ, Zhu X, Landersdorfer C, et al
    How important are MIC determination methods when targeting vancomycin levels in patients with Staphylococcus aureus infections?
    J Antimicrob Chemother. 2021 Mar 18. pii: 6177478. doi: 10.1093.
    PubMed    


  92. FALCONE M, Tiseo G, Giordano C, Leonildi A, et al
    Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
    J Antimicrob Chemother. 2021;76:1078-1084.
    PubMed     Abstract available


  93. NURNBERG S, Claus H, Krone M, Vogel U, et al
    Cefotaxime resistance in invasive Haemophilus influenzae isolates in Germany 2016-19: prevalence, epidemiology and relevance of PBP3 substitutions.
    J Antimicrob Chemother. 2021;76:920-929.
    PubMed     Abstract available


  94. VERSCHUUREN TD, van Hout D, Arredondo-Alonso S, Fluit AC, et al
    Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014-17).
    J Antimicrob Chemother. 2021;76:901-908.
    PubMed     Abstract available


  95. CORTAZZO V, Giordano L, D'Inzeo T, Fiori B, et al
    EUCAST rapid antimicrobial susceptibility testing of blood cultures positive for Escherichia coli or Klebsiella pneumoniae: experience of three laboratories in Italy.
    J Antimicrob Chemother. 2021;76:1110-1112.
    PubMed    


  96. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed     Abstract available


  97. ZHENG Z, Ye L, Li R, Chen S, et al
    Whole-genome sequencing of strains of Vibrio spp. from China reveals different genetic contexts of blaCTX-M-14 among diverse lineages.
    J Antimicrob Chemother. 2021;76:950-956.
    PubMed     Abstract available


  98. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed     Abstract available


  99. AHMADI MH
    Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2021;76:865-875.
    PubMed     Abstract available


  100. DIEZ-AGUILAR M, Hernandez-Garcia M, Morosini MI, Fluit A, et al
    Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
    J Antimicrob Chemother. 2021;76:984-992.
    PubMed     Abstract available


  101. COLLINS DA, Wu Y, Tateda K, Kim HJ, et al
    Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    J Antimicrob Chemother. 2021;76:967-972.
    PubMed     Abstract available


  102. LIN EY, Adamson PC, Klausner JD
    Evaluating the generalizability of a multiplex real-time PCR assay for predicting decreased susceptibility to ceftriaxone in a global set of Neisseria gonorrhoeae sequences.
    J Antimicrob Chemother. 2021;76:1104-1106.
    PubMed    


  103. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed     Abstract available


  104. CHEW KL, Octavia S, Go J, Ng S, et al
    In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens.
    J Antimicrob Chemother. 2021;76:973-978.
    PubMed     Abstract available


  105. NUCCI M, Jenks J, Thompson GR, Hoenigl M, et al
    Do high MICs predict the outcome in invasive fusariosis?
    J Antimicrob Chemother. 2021;76:1063-1069.
    PubMed     Abstract available


  106. BENTZ ML, Nunnally N, Lockhart SR, Sexton DJ, et al
    Antifungal activity of nikkomycin Z against Candida auris.
    J Antimicrob Chemother. 2021 Mar 3. pii: 6157462. doi: 10.1093.
    PubMed     Abstract available


  107. SHANG Y, Lv P, Li S, Wang W, et al
    Allele-based analysis revealed the critical functions of region 277-297 in the NorA efflux pump of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Mar 3. pii: 6157432. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  108. FERNANDEZ-HUERTA M, Serra-Pladevall J, Pumarola T, Pich OQ, et al
    Comment on: Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2021 Feb 28. pii: 6154381. doi: 10.1093.
    PubMed    


  109. PORTAL E, Descours G, Ginevra C, Mentasti M, et al
    Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?
    J Antimicrob Chemother. 2021 Feb 20. pii: 6145330. doi: 10.1093.
    PubMed     Abstract available


  110. RACHINA S, Zakharenkov I, Dekhnich N, Kozlov R, et al
    Aetiology of severe community-acquired pneumonia and antimicrobial susceptibility of Streptococcus pneumoniae in adults in Russia.
    J Antimicrob Chemother. 2021 Feb 19. pii: 6144791. doi: 10.1093.
    PubMed    


  111. BROWN NM, Brown EM
    Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK.
    J Antimicrob Chemother. 2021 Feb 14. pii: 6134889. doi: 10.1093.
    PubMed     Abstract available


  112. WANG L, Amin AK, Khanna P, Aali A, et al
    An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    J Antimicrob Chemother. 2021;76:796-803.
    PubMed     Abstract available


  113. SALMERON P, Vinado B, Arando M, Alcoceba E, et al
    Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
    J Antimicrob Chemother. 2021 Feb 11. pii: 6132746. doi: 10.1093.
    PubMed     Abstract available


  114. TAKEBAYASHI Y, Findlay J, Heesom KJ, Warburton PJ, et al
    Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.
    J Antimicrob Chemother. 2021;76:587-595.
    PubMed     Abstract available


  115. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed     Abstract available


  116. WOLTER DJ, Scott A, Armbruster CR, Whittington D, et al
    Repeated isolation of an antibiotic-dependent and temperature-sensitive mutant of Pseudomonas aeruginosa from a cystic fibrosis patient.
    J Antimicrob Chemother. 2021;76:616-625.
    PubMed     Abstract available


  117. KUO SC, Tan MC, Huang WC, Wu HC, et al
    Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods.
    J Antimicrob Chemother. 2021;76:653-658.
    PubMed     Abstract available


  118. SPRUTE R, Salmanton-Garcia J, Sal E, Malaj X, et al
    Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope(R) registry and literature reports.
    J Antimicrob Chemother. 2021;76:765-774.
    PubMed     Abstract available


  119. KARAISKOS I, Daikos GL, Gkoufa A, Adamis G, et al
    Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.
    J Antimicrob Chemother. 2021;76:775-783.
    PubMed     Abstract available


  120. BALTAS I, Stockdale T, Tausan M, Kashif A, et al
    Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time.
    J Antimicrob Chemother. 2021;76:813-819.
    PubMed     Abstract available


  121. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed     Abstract available


  122. TIETGEN M, Leukert L, Sommer J, Kramer JS, et al
    Characterization of the novel OXA-213-like beta-lactamase OXA-822 from Acinetobacter calcoaceticus.
    J Antimicrob Chemother. 2021;76:626-634.
    PubMed     Abstract available


  123. COLOMBO AL, Agnelli C, Kontoyiannis DP
    Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients.
    J Antimicrob Chemother. 2021;76:543-546.
    PubMed     Abstract available


  124. FERNANDEZ-CUENCA F, Lopez-Hernandez I, Cercenado E, Conejo C, et al
    Reporting antimicrobial susceptibilities and resistance phenotypes in Staphylococcus spp.: a nationwide proficiency study.
    J Antimicrob Chemother. 2021 Feb 8. pii: 6130710. doi: 10.1093.
    PubMed     Abstract available


  125. LE ROY C, Touati A, Balcon C, Garraud J, et al
    Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis.
    J Antimicrob Chemother. 2021 Feb 4. pii: 6127604. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  126. GIANNELLA M, Bartoletti M, Conti M, Righi E, et al
    Carbapenemase-producing Enterobacteriaceae in transplant patients.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  127. TSIOUTIS C, Eichel VM, Mutters NT
    Transmission of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: the role of infection control.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  128. CARRARA E, Conti M, Meschiari M, Mussini C, et al
    The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  129. KERNEIS S, Lucet JC, Santoro A, Meschiari M, et al
    Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  130. PAUL M
    Management of KPC-producing Klebsiella pneumoniae in clinical practice: introduction.
    J Antimicrob Chemother. 2021;76.
    PubMed    


  131. GOMEZ-SIMMONDS A, Annavajhala MK, McConville TH, Dietz DE, et al
    Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.
    J Antimicrob Chemother. 2021;76:380-384.
    PubMed     Abstract available


  132. MOSER AI, Kuenzli E, Budel T, Campos-Madueno EI, et al
    Travellers returning from the island of Zanzibar colonized with MDR Escherichia coli strains: assessing the impact of local people and other sources.
    J Antimicrob Chemother. 2021;76:330-337.
    PubMed     Abstract available


  133. CAMARA J, Grau I, Gonzalez-Diaz A, Tubau F, et al
    A historical perspective of MDR invasive pneumococcal disease in Spanish adults.
    J Antimicrob Chemother. 2021;76:507-515.
    PubMed     Abstract available


  134. MARI-ALMIRALL M, Cosgaya C, Pitart C, Vines J, et al
    Dissemination of NDM-producing Klebsiella pneumoniae and Escherichia coli high-risk clones in Catalan healthcare institutions.
    J Antimicrob Chemother. 2021;76:345-354.
    PubMed     Abstract available


  135. DI PILATO V, Errico G, Monaco M, Giani T, et al
    The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages.
    J Antimicrob Chemother. 2021;76:355-361.
    PubMed     Abstract available


  136. PAULY N, Hammerl JA, Schwarz S, Grobbel M, et al
    Co-occurrence of the blaVIM-1 and blaSHV-12 genes on an IncHI2 plasmid of an Escherichia coli isolate recovered from German livestock.
    J Antimicrob Chemother. 2021;76:531-533.
    PubMed    


  137. SILVA L, Grosso F, Rodrigues C, Ksiezarek M, et al
    The success of particular Acinetobacter baumannii clones: accumulating resistance and virulence inside a sugary shield.
    J Antimicrob Chemother. 2021;76:305-311.
    PubMed     Abstract available


  138. AULIN LBS, Koumans CIM, Haakman Y, van Os W, et al
    Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76:533-535.
    PubMed    


  139. MAILLARD A, Scemla A, Laffy B, Mahloul N, et al
    Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study.
    J Antimicrob Chemother. 2021;76:487-494.
    PubMed     Abstract available


  140. LI LH, Yang YS, Sun JR, Huang TW, et al
    Clinical and molecular characterization of Acinetobacter seifertii in Taiwan.
    J Antimicrob Chemother. 2021;76:312-321.
    PubMed     Abstract available


  141. LEE YM, Moon C, Park KH
    Is short-term antibiotic therapy safe in patients with central venous catheter-related Gram-negative bacteraemia?
    J Antimicrob Chemother. 2021;76:539-541.
    PubMed    


  142. HERNANDEZ-GARCIA M, Garcia-Castillo M, Garcia-Fernandez S, Melo-Cristino J, et al
    Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    J Antimicrob Chemother. 2021;76:370-379.
    PubMed     Abstract available


  143. AIHARA M, Nishida R, Akimoto M, Gotoh Y, et al
    Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance.
    J Antimicrob Chemother. 2021;76:362-369.
    PubMed     Abstract available


  144. HAMIDIAN M, Ambrose SJ, Blackwell GA, Nigro SJ, et al
    An outbreak of multiply antibiotic-resistant ST49:ST128:KL11:OCL8 Acinetobacter baumannii isolates at a Sydney hospital.
    J Antimicrob Chemother. 2021 Jan 16. pii: 6102239. doi: 10.1093.
    PubMed     Abstract available


  145. SWEENEY EL, Lowry K, Bletchly C, Nimmo GR, et al
    Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains.
    J Antimicrob Chemother. 2021 Jan 15. pii: 6100778. doi: 10.1093.
    PubMed     Abstract available


  146. ZHU Y, Zhang W, Liu S, Schwarz S, et al
    Identification of an IS431-derived translocatable unit containing the erm(C) gene in Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jan 11. pii: 6082781. doi: 10.1093.
    PubMed    


  147. GOLPARIAN D, Sanchez-Buso L, Cole M, Unemo M, et al
    Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions.
    J Antimicrob Chemother. 2021 Jan 7. pii: 6067623. doi: 10.1093.
    PubMed     Abstract available


  148. BUDIN S, Salmanton-Garcia J, Koehler P, Stemler J, et al
    Validation of the EQUAL Aspergillosis Score by analysing guideline-adherent management of invasive pulmonary aspergillosis.
    J Antimicrob Chemother. 2021 Jan 4. pii: 6062083. doi: 10.1093.
    PubMed     Abstract available


  149. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed     Abstract available


  150. BEZABIH YM, Sabiiti W, Alamneh E, Bezabih A, et al
    The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community.
    J Antimicrob Chemother. 2021;76:22-29.
    PubMed     Abstract available


  151. ARCA-SUAREZ J, Lasarte-Monterrubio C, Rodino-Janeiro BK, Cabot G, et al
    Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
    J Antimicrob Chemother. 2021;76:91-100.
    PubMed     Abstract available


  152. DUGGETT N, Ellington MJ, Hopkins KL, Ellaby N, et al
    Detection in livestock of the human pandemic Escherichia coli ST131 fimH30(R) clone carrying blaCTX-M-27.
    J Antimicrob Chemother. 2021;76:263-265.
    PubMed    


  153. KHANINA A, Urbancic KF, Haeusler GM, Kong DCM, et al
    Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey.
    J Antimicrob Chemother. 2021;76:253-262.
    PubMed     Abstract available


  154. PEREZ-VISO B, Hernandez-Garcia M, Ponce-Alonso M, Morosini MI, et al
    Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016-18).
    J Antimicrob Chemother. 2021;76:110-116.
    PubMed     Abstract available


  155. TREMBIZKI E, Jennison AV, Buckley C, Bright A, et al
    Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia.
    J Antimicrob Chemother. 2021;76:270-271.
    PubMed    


  156. LOUKA C, Ravensbergen SJ, Ott A, Zhou X, et al
    Predominance of CTX-M-15-producing ST131 strains among ESBL-producing Escherichia coli isolated from asylum seekers in the Netherlands.
    J Antimicrob Chemother. 2021;76:70-76.
    PubMed     Abstract available


  157. BOEL JB, Antsupova V, Knudsen JD, Jarlov JO, et al
    Intravenous mecillinam compared with other beta-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus.
    J Antimicrob Chemother. 2021;76:206-211.
    PubMed     Abstract available


  158. TANG Y, Lai Y, Kong L, Wang X, et al
    Characterization of three porcine Escherichia coli isolates co-harbouring tet(X4) and cfr.
    J Antimicrob Chemother. 2021;76:263-264.
    PubMed    


  159. KUMWENDA GP, Sugawara Y, Akeda Y, Matsumoto Y, et al
    Genomic features of plasmids coding for KPC-2, NDM-5 or OXA-48 carbapenemases in Enterobacteriaceae from Malawi.
    J Antimicrob Chemother. 2021;76:267-270.
    PubMed    


  160. ABBOTSFORD J, Foley DA, Goff Z, Bowen AC, et al
    Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.
    J Antimicrob Chemother. 2021;76:249-252.
    PubMed     Abstract available


  161. BUCKLEY AM, Altringham J, Clark E, Bently K, et al
    Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut model.
    J Antimicrob Chemother. 2021;76:171-178.
    PubMed     Abstract available


    December 2020
  162. ALGHAMDI WA, Al-Shaer MH, Kipiani M, Barbakadze K, et al
    Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis.
    J Antimicrob Chemother. 2020 Dec 30. pii: 6055881. doi: 10.1093.
    PubMed     Abstract available


  163. CRUCIANI M, White PL, Mengoli C, Loffler J, et al
    The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.
    J Antimicrob Chemother. 2020 Dec 29. pii: 6055077. doi: 10.1093.
    PubMed     Abstract available


  164. WEINER M, Gelfond J, Johnson-Pais TL, Engle M, et al
    Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
    J Antimicrob Chemother. 2020 Dec 29. pii: 6055076. doi: 10.1093.
    PubMed     Abstract available


  165. XANTHOPOULOU K, Wille J, Zweigner J, Lucassen K, et al
    Characterization of a vancomycin-resistant Enterococcus faecium isolate and a vancomycin-susceptible E. faecium isolate from the same blood culture.
    J Antimicrob Chemother. 2020 Dec 28. pii: 6054276. doi: 10.1093.
    PubMed     Abstract available


  166. WAGNER TM, Janice J, Sivertsen A, Sjogren I, et al
    Alternative vanHAX promoters and increased vanA-plasmid copy number resurrect silenced glycopeptide resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Dec 26. pii: 6050581. doi: 10.1093.
    PubMed     Abstract available


  167. BLACKMAN A, Morrison B, Maruri F, van der Heijden Y, et al
    Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2020 Dec 23. pii: 6046147. doi: 10.1093.
    PubMed    


  168. LARRAMENDY S, Gaultier A, Fournier JP, Caillon J, et al
    Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study.
    J Antimicrob Chemother. 2020 Dec 22. pii: 6042378. doi: 10.1093.
    PubMed     Abstract available


  169. TAHSEEN S, vanDeun A, de Jong BC, Decroo T, et al
    Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?
    J Antimicrob Chemother. 2020 Dec 1. pii: 6015577. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  170. ZHU Y, Wang C, Schwarz S, Liu W, et al
    Identification of a novel tetracycline resistance gene, tet(63), located on a multiresistance plasmid from Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Nov 28. pii: 6008797. doi: 10.1093.
    PubMed     Abstract available


  171. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Ilkit M, et al
    Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2020 Nov 11. pii: 5974114. doi: 10.1093.
    PubMed     Abstract available


  172. SHROPSHIRE WC, Aitken SL, Pifer R, Kim J, et al
    IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
    J Antimicrob Chemother. 2020 Nov 9. pii: 5961599. doi: 10.1093.
    PubMed     Abstract available


  173. HAYAJNEH WA, Al-Azzam S, Yusef D, Lattyak WJ, et al
    Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan.
    J Antimicrob Chemother. 2020 Nov 5. pii: 5957247. doi: 10.1093.
    PubMed     Abstract available


  174. MIZUSHIMA D, Takano M, Uemura H, Yanagawa Y, et al
    Effectiveness of doxycycline 100 mg twice daily for 7 days and azithromycin 1 g single dose for the treatment of rectal Chlamydia trachomatis infection among men who have sex with men.
    J Antimicrob Chemother. 2020 Nov 4. pii: 5955928. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  175. TKADLEC J, Capek V, Brajerova M, Smelikova E, et al
    The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic.
    J Antimicrob Chemother. 2020 Oct 29. pii: 5942696. doi: 10.1093.
    PubMed     Abstract available


  176. GUIRAUD J, Lounnas M, Boissiere A, Le Roy C, et al
    Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2020 Oct 20. pii: 5930856. doi: 10.1093.
    PubMed     Abstract available


  177. YANG Q, Li X, Jia P, Giske C, et al
    Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis.
    J Antimicrob Chemother. 2020 Oct 14. pii: 5923762. doi: 10.1093.
    PubMed     Abstract available


  178. ARA-MONTOJO MF, Escosa-Garcia L, Alguacil-Guillen M, Seara N, et al
    Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    J Antimicrob Chemother. 2020 Oct 10. pii: 5920733. doi: 10.1093.
    PubMed     Abstract available


  179. PAPATHANAKOS G, Andrianopoulos I, Papathanasiou A, Koulenti D, et al
    Pandrug-resistant Acinetobacter baumannii treatment: still a debatable topic with no definite solutions.
    J Antimicrob Chemother. 2020;75:3081.
    PubMed    


    September 2020
  180. HADAD R, Cole MJ, Ebeyan S, Jacobsson S, et al
    Evaluation of the SpeeDx ResistancePlus(R) GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905664. doi: 10.1093.
    PubMed     Abstract available


  181. ROUX J, Nekkab N, Colomb-Cotinat M, Astagneau P, et al
    Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905635. doi: 10.1093.
    PubMed     Abstract available


  182. AMBROSE SJ, Hall RM
    A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905668. doi: 10.1093.
    PubMed    


    August 2020
  183. RICHELSEN R, Smit J, Schonheyder HC, Laxsen Anru P, et al
    Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899248. doi: 10.1093.
    PubMed     Abstract available


  184. DIACONU EL, Carfora V, Alba P, Di Matteo P, et al
    Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
    J Antimicrob Chemother. 2020 Aug 24. pii: 5896583. doi: 10.1093.
    PubMed     Abstract available


  185. LYU T, Cheung KS, Ni L, Guo J, et al
    High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891805. doi: 10.1093.
    PubMed     Abstract available


  186. GOLPARIAN D, Bazzo ML, Golfetto L, Gaspar PC, et al
    Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891806. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  187. DAI VTT, Beissbarth J, Thanh PV, Hoan PT, et al
    Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878176. doi: 10.1093.
    PubMed     Abstract available


  188. LI Y, Xiu L, Liu J, Zhang C, et al
    A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
    J Antimicrob Chemother. 2020 Jul 20. pii: 5874078. doi: 10.1093.
    PubMed     Abstract available


  189. CHAN AP, Choi Y, Clarke TH, Brinkac LM, et al
    AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2020 Jul 18. pii: 5873331. doi: 10.1093.
    PubMed     Abstract available


  190. ZHANG S, Wang X, Wise MJ, He Y, et al
    Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.
    J Antimicrob Chemother. 2020 Jul 17. pii: 5872801. doi: 10.1093.
    PubMed     Abstract available


  191. RIVAYA B, Jordana-Lluch E, Fernandez-Rivas G, Molinos S, et al
    Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    J Antimicrob Chemother. 2020 Jul 12. pii: 5870410. doi: 10.1093.
    PubMed     Abstract available


  192. CAO T, Liu Y, Li Y, Wang Y, et al
    A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment.
    J Antimicrob Chemother. 2020 Jul 4. pii: 5867249. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  193. SEIFERT H, Muller C, Stefanik D, Higgins PG, et al
    In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855123. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  194. LAM TT, Nurnberg S, Claus H, Vogel U, et al
    Molecular epidemiology of imipenem resistance in invasive Haemophilus influenzae infections in Germany in 2016.
    J Antimicrob Chemother. 2020 May 25. pii: 5843865. doi: 10.1093.
    PubMed     Abstract available


  195. STEWART AG, Harris PNA, Henderson A, Schembri MA, et al
    Oral cephalosporin and beta-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
    J Antimicrob Chemother. 2020 May 22. pii: 5842233. doi: 10.1093.
    PubMed     Abstract available


  196. DE LASTOURS V, Laouenan C, Royer G, Carbonnelle E, et al
    Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    J Antimicrob Chemother. 2020 May 17. pii: 5838343. doi: 10.1093.
    PubMed     Abstract available


  197. MARTINEZ EP, van Rosmalen J, Bustillos R, Natsch S, et al
    Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    J Antimicrob Chemother. 2020 May 17. pii: 5838345. doi: 10.1093.
    PubMed     Abstract available


  198. CHANAME PINEDO LE, Bruyndonckx R, Catry B, Latour K, et al
    Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study.
    J Antimicrob Chemother. 2020 May 12. pii: 5836063. doi: 10.1093.
    PubMed     Abstract available


  199. ABBOTT IJ, van Gorp E, Wijma RA, Dekker J, et al
    Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model.
    J Antimicrob Chemother. 2020 May 3. pii: 5828355. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  200. ROHDE AM, Zweigner J, Wiese-Posselt M, Schwab F, et al
    Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals.
    J Antimicrob Chemother. 2020 Mar 16. pii: 5805542. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  201. LAN PT, Golparian D, Ringlander J, Van Hung L, et al
    Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16.
    J Antimicrob Chemother. 2020 Feb 18. pii: 5740025. doi: 10.1093.
    PubMed     Abstract available


  202. BOURELY C, Coeffic T, Caillon J, Thibaut S, et al
    Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals.
    J Antimicrob Chemother. 2020 Feb 12. pii: 5734707. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  203. PAINSET A, Day M, Doumith M, Rigby J, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015-16.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707358. doi: 10.1093.
    PubMed     Abstract available


  204. XIU L, Zhang C, Li Y, Wang F, et al
    High-resolution melting analysis for rapid detection of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone.
    J Antimicrob Chemother. 2020;75:106-109.
    PubMed     Abstract available


  205. SOREN O, Rineh A, Silva DG, Cai Y, et al
    Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2020;75:117-125.
    PubMed     Abstract available


  206. KIDD JM, Abdelraouf K, Nicolau DP
    Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
    J Antimicrob Chemother. 2020;75:149-155.
    PubMed     Abstract available


  207. PAUL D, Babenko D, Toleman MA
    Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.
    J Antimicrob Chemother. 2020;75:72-76.
    PubMed     Abstract available


  208. WAREHAM DW, Momin MHFA, Phee LM, Hornsey M, et al
    Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
    J Antimicrob Chemother. 2020;75:135-139.
    PubMed     Abstract available


  209. KIM J, Nakwa FL, Araujo Motta F, Liu H, et al
    A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age.
    J Antimicrob Chemother. 2020;75:215-220.
    PubMed     Abstract available


  210. MARTINEZ-GUITIAN M, Vazquez-Ucha JC, Alvarez-Fraga L, Conde-Perez K, et al
    Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide-PNA conjugates and synergy with colistin.
    J Antimicrob Chemother. 2020;75:51-59.
    PubMed     Abstract available


  211. LUO Q, Wan F, Yu X, Zheng B, et al
    MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    J Antimicrob Chemother. 2020;75:92-95.
    PubMed     Abstract available


  212. SCHNEEWEISS S, Carver PL, Datta K, Galar A, et al
    Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
    J Antimicrob Chemother. 2020;75:221-228.
    PubMed     Abstract available


  213. MARTINS-SORENSON N, Snesrud E, Xavier DE, Cacci LC, et al
    A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    J Antimicrob Chemother. 2020;75:60-64.
    PubMed     Abstract available


  214. FINDLAY J, Gould VC, North P, Bowker KE, et al
    Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
    J Antimicrob Chemother. 2020;75:65-71.
    PubMed     Abstract available


    December 2019
  215. ABBOTT IJ, Dekker J, van Gorp E, Wijma RA, et al
    Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections.
    J Antimicrob Chemother. 2019 Dec 24. pii: 5686404. doi: 10.1093.
    PubMed     Abstract available


  216. LO SW, Gladstone RA, van Tonder AJ, Du Plessis M, et al
    A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650366. doi: 10.1093.
    PubMed     Abstract available


  217. HAYAKAWA K, Nakano R, Hase R, Shimatani M, et al
    Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650359. doi: 10.1093.
    PubMed     Abstract available


  218. SAVOLDI A, Carrara E, Gladstone BP, Azzini AM, et al
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    J Antimicrob Chemother. 2019;74:3619-3625.
    PubMed     Abstract available


    November 2019
  219. LESTER R, Musicha P, van Ginneken N, Dramowski A, et al
    Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632029. doi: 10.1093.
    PubMed     Abstract available


  220. ZHANG Y, Jin L, Ouyang P, Wang Q, et al
    Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
    J Antimicrob Chemother. 2019 Nov 12. pii: 5622907. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  221. BRITTO CD, Dyson ZA, Mathias S, Bosco A, et al
    Persistent circulation of a fluoroquinolone-resistant Salmonella enterica Typhi clone in the Indian subcontinent.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607520. doi: 10.1093.
    PubMed     Abstract available


  222. JAHAN MI, Rahaman MM, Hossain MA, Sultana M, et al
    Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of beta-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
    J Antimicrob Chemother. 2019 Oct 24. pii: 5606763. doi: 10.1093.
    PubMed     Abstract available


  223. BIRGY A, Madhi F, Jung C, Levy C, et al
    Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588579. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  224. EIGENBROD T, Reuter S, Gross A, Kocer K, et al
    Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15.
    J Antimicrob Chemother. 2019 Aug 31. pii: 5557811. doi: 10.1093.
    PubMed     Abstract available


  225. COOMBS GW, Mowlaboccus S, Daley D, Lee T, et al
    Sulfamethoxazole/trimethoprim resistance overcall by VITEK(R) 2 and BD Phoenix in community-associated MRSA and MSSA.
    J Antimicrob Chemother. 2019 Aug 20. pii: 5552317. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: